Infectious Diseases Market Research Reports & Industry Analysis
Infectious Diseases Industry Research & Market Reports
-
Impact of Covid-19 on Pharmaceuticals Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
... of Covid-19 on the pharmaceuticals market size was valued at USD 1,494.67 billion in 2021, and the market is now projected to grow from USD 1,585.05 billion in 2022 to USD 2,401.22 billion by 2029, ... Read More
-
2024 North America Hospital Acquired Infection Control Market Forecast (2025-2030 Outlook)-Market Opportunities Report
... the NAICS Healthcare industry. market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service ... Read More
-
2024 United States Hospital Acquired Infection Control Market Forecast (2025-2030 Outlook)-Market Opportunities Report
... the NAICS Healthcare industry. market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service ... Read More
-
2024 United Kingdom Hospital Acquired Infection Control Market Forecast (2025-2030 Outlook)-Market Opportunities Report
... the NAICS Healthcare industry. market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service ... Read More
-
2024 Global Hospital Acquired Infection Control Market Forecast (2025-2030 Outlook)-Market Opportunities Report
... NAICS Healthcare industry. market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service sales ... Read More
-
2024 Germany Hospital Acquired Infection Control Market Forecast (2025-2030 Outlook)-Market Opportunities Report
... NAICS Healthcare industry. market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service sales ... Read More
-
2024 Certain Infectious and Parasitic Diseases Global Market Size & Growth Report with Updated Analysis & Forecasts
... growth, and share across 4 global regions (The Americas, Europe, Asia & Oceania, Africa & Middle East), 22 subregions, and 195 countries. Figures are from 2012 through 2023, with forecasts for 2024 and 2028. The ... Read More
-
Latin America Chemiluminescence Immunoassay Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Application (Oncology, Fertility, Endocrinology, Cardiology, Infectious Diseases, Diabetes, and Others), End User (Hospitals, Blood Banks, Clinical Laboratories, Pharmaceutical & Biotech Companies, and Others), and Country
... Banks, Clinical Laboratories, Pharmaceutical & Biotech Companies, and Others), and Country The Latin America chemiluminescence immunoassay market size is expected to grow from US$ 497.67 million in 2023 and is projected to reach US$ 955.12 ... Read More
-
Global Cytomegalovirus (CMV) Therapeutics Market 2024-2028
... (CMV) therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market ... Read More
-
North America RNA Therapeutics Market, By Product (Vaccines, Drugs), By Type (mRNA Therapeutics, RNA Interference (RNAi) Therapeutics, Antisense Oligonucleotide (ASO) Therapeutics, Other Therapeutics), By Indication (Infectious Diseases, Rare Genetic Diseases/Hereditary Diseases, Other Indications), By End User (Hospitals and Clinics, Ambulatory Surgical Centers, Others), By Country, Competition, Forecast and Opportunities, 2019-2029F
... User (Hospitals and Clinics, Ambulatory Surgical Centers, Others), By Country, Competition, Forecast and Opportunities, 2019-2029F North America RNA Therapeutics Market was valued at USD 12.95 billion in 2023 and is anticipated to project robust growth ... Read More
-
Infectious Disease Therapeutics
... at a CAGR of 7.1% over the analysis period 2023-2030. HIV Disease Therapeutics, one of the segments analyzed in the report, is expected to record a 8.1% CAGR and reach US$113.7 Billion by the end ... Read More
-
Clinical Trials Market Analysis and Forecast to 2033: By Phase (Phase I, Phase Ii, Phase Iii, Phase Iv, Preclinical), Design (Interventional Trials, Observational Trials, Expanded Access Trials), Indication (Oncology, Cardiology, Neurology, Infectious Diseases, Gastroenterology, Immunology, Respiratory, Endocrinology, Dermatology, Ophthalmology), Study Type (Randomized Controlled Trials, Non-Randomized Controlled Trials, Adaptive Trials, Single-Arm Trials), Service Type (Clinical Trial Management, Patient Recruitment, Laboratory Services, Data Management), End User (Pharmaceutical Companies, Contract Research Organizations, Academic Institutions, Medical Device Manufacturers, Public Health Organizations), and Region
... Respiratory, Endocrinology, Dermatology, Ophthalmology), Study Type (Randomized Controlled Trials, Non-Randomized Controlled Trials, Adaptive Trials, Single-Arm Trials), Service Type (Clinical Trial Management, Patient Recruitment, Laboratory Services, Data Management), End User (Pharmaceutical Companies, Contract Research Organizations, Academic ... Read More
-
Global Pneumococcal Vaccine Market 2024-2028
... provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the latest ... Read More
-
Human Microbiome Market by Product (Drugs, Probiotics, Prebiotics, Synbiotics), Diseases (Infectious, Gastrointestinal, Endocrine & Metabolic), Type (BCT/FMT, Live Biotherapeutics), End User (Hospitals, Clinics, Long-term Care) - Global Forecast to 2030
... expected to reach USD 4,206.0 million in 2030 from USD 814.6 million in 2024, at a CAGR of 31.5% during the forecast period. Factors such as the collaborative efforts between the microbiome industry and academia ... Read More
-
Clinical Trials Market Assessment, By Phase [Phase I, Phase II, Phase III, and Phase IV], By Service Type [Laboratory Services, Bioanalytical and Analytical Testing Services, Patient Recruitment and Site Identification, Clinical Trial Data Management Services, Protocol Designing, Medical Device Testing Services, Other Services], By Therapeutic Area [Oncology, Cardiology, Neurology, Infectious Diseases, Other Therapeutic Areas], By Application [Small Molecules, Vaccines, Cell and Gene Therapies, Monoclonal Antibodies, Other Applications], By Study Designs Outlook [Interventional, Observational, Expanded Access], By Sponsor Type [Pharmaceutical Companies, Medical Devices Companies, Academic Institutes], By Region, Opportunities and Forecast, 2017-2031F
... Protocol Designing, Medical Device Testing Services, Other Services], By Therapeutic Area [Oncology, Cardiology, Neurology, Infectious Diseases, Other Therapeutic Areas], By Application [Small Molecules, Vaccines, Cell and Gene Therapies, Monoclonal Antibodies, Other Applications], By Study Designs ... Read More
-
Pharmacogenomics Market Report by Technology (Polymerase Chain Reaction, Microarray, DNA Sequencing, Mass Spectrometry, Electrophoresis, and Others), Application (Oncology, Infectious Diseases, Cardiovascular Diseases, Neurological Diseases, Psychiatry, Pain Management, and Others), End User (Hospitals and Clinics, Academic and Research Institutes), and Region 2024-2032
... and Research Institutes), and Region 2024-2032 The global pharmacogenomics market size reached US$ 7.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 16.1 Billion by 2032, exhibiting a growth rate ... Read More
-
Microbial Identification Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War
... 2025-2034. This report on global microbial identification market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global microbial ... Read More
-
Zika Virus Testing
... by 2030, growing at a CAGR of 5.7% over the analysis period 2023-2030. Molecular Testing, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$192.4 Million by ... Read More
-
2024 Global West Nile Diagnostics Market: US, Europe, Japan - Supplier Shares, Sales Segment Forecasts, Innovative Technologies and Tests, Competitive Profiles and Strategies Locations
... Europe (France, Germany, Italy, Spain, UK) and Japan. The report provides volume and sales forecasts for West Nile tests performed in the following market segments: Hospitals Commercial/Private Labs Physician Offices Public Health Labs Please note: ... Read More
-
2024 Global Pneumonia Diagnostics Market: US, Europe, Japan - Supplier Shares, Sales Segment Forecasts, Innovative Technologies and Tests, Competitive Profiles and Strategies
... US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Pneumonia definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the ... Read More
-
2024 Global Coronavirus Diagnostics Market: US, Europe, Japan - Supplier Shares, Sales Segment Forecasts, Innovative Technologies and Tests, Competitive Profiles and Strategies
... US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Coronavirus definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the ... Read More
-
Global Nucleic Acid Therapeutics Market Size study, by Product (Anti-Sense Oligonucleotides (ASO), RNA Interference (RNAi), RNA Aptamers), by Indication (Autoimmune Disorders, Infectious Diseases, Genetic Disorders, Cancer, Others), by End-user (Hospitals, Physicians’ Offices, Others), and Regional Forecasts 2022-2032
... Forecasts 2022-2032 The Global Nucleic Acid Therapeutics Market was valued at approximately USD 6.0 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 12.8% over the forecast period ... Read More
-
Molecular Diagnostics Market Assessment, By Product and Service [Reagents and Kits, Instruments, Services and Software], By Test Type [Lab Tests, POC Tests], By Sample Type [Blood, Serum, and Plasma, Urine, Others], By Technology [Polymerase Chain Reaction, Isothermal Nucleic Acid Amplification Technology, In-situ Hybridization, DNA Sequencing, Microarray, Others], By Application [Infectious Diseases Tests, Oncology Tests, Genetic Tests, Others], By End-user [Hospitals and Clinics, Diagnostic Laboratories, Others], By Region, Opportunities and Forecast, 2017-2031F
... Reaction, Isothermal Nucleic Acid Amplification Technology, In-situ Hybridization, DNA Sequencing, Microarray, Others], By Application [Infectious Diseases Tests, Oncology Tests, Genetic Tests, Others], By End-user [Hospitals and Clinics, Diagnostic Laboratories, Others], By Region, Opportunities and Forecast, ... Read More
-
2024 Germany Hospital Infectious Disease Market for 100 Tests: Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Technologies, Instrumentation and Opportunities
... a comprehensive analysis of the German hospital infectious disease testing market, including: Major issues pertaining to the German hospital laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market ... Read More
-
2024 UK Hospital Infectious Disease Market: Supplier Shares by Test, Volume and Sales Segment Forecasts for 100 Tests, Competitive Landscape, Innovative Technologies, Instrumentation Review, Opportunities for Suppliers
... and 67 tables. The report presents a comprehensive analysis of the UK hospital infectious disease testing market, including: Major issues pertaining to the UK hospital laboratory practice, as well as key economic, regulatory, demographic, social ... Read More
Research Assistance
